Otonomy to Present at Cantor Fitzgerald Global Healthcare Conference

Back to Jobs

SAN DIEGO , Sept. 25, 2018 (GLOBE NEWSWIRE) — Otonomy , Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced that David A. Weber , Ph.D., president and chief executive officer, will present at the 2018 Cantor

Apply Now